Status:
COMPLETED
Effects of High Ventilation Breathwork With Retention (HVBR) on Health
Lead Sponsor:
University of Sussex
Collaborating Sponsors:
Sylff Association
Brighton & Sussex Medical School
Conditions:
Stress
Anxiety
Eligibility:
All Genders
18-39 years
Phase:
NA
Brief Summary
The investigators are conducting a randomised-controlled trial comparing high ventilation breathwork with retention (HVBR) to a breathwork placebo (paced breathing at 15breaths/min with brief retentio...
Eligibility Criteria
Inclusion
- Inclusion Criteria (self-assessed):
- Fluent in English and living in the UK
- Have access to headphones
- Comfortable with faster breathing and holding breath
- Willing to only practice breathwork in safe environment, lying down in soft area (i.e., bed, sofa, carpet/mat), and always away from water \& hard ground
- Willing to only practice the breathwork away from large meals (i.e., before or 1hour after) and bedtime (i.e., at least 1 hour before if practicing in evening)
- Exclusion Criteria (self-assessed):
- Hypotension or hypertension (low or high blood pressure)
- History of respiratory or cardiovascular/heart problems or disease
- History of fainting or syncope
- Epilepsy or seizures
- History of panic disorder or panic attacks
- Cerebral aneurysm
- Have had problems with prior breathwork sessions (i.e., fainting)
- Pregnancy, think one might be pregnant, trying to get pregnant, or are breastfeeding
- Any problems which affect one's ability to pace their breathing (i.e., active/chronic respiratory infection including blocked nose/cough/cold/fever, etc.), breathlessness, abnormally slow breathing (bradypnea), or abnormally fast breathing (tachypnoea)
- Any other physical/mental health conditions or current life events which impair or affect one's ability to engage in activities involving breath control
- Are taking any regular medication other than the contraceptive pill, including medications to reduce blood pressure (i.e., Ramipril or other ACE-inhibitors), beta blockers (i.e., Propranolol), antidepressants, anxiolytics or any other psychotropic medications
Exclusion
Key Trial Info
Start Date :
October 13 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 11 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06064474
Start Date
October 13 2023
End Date
December 11 2023
Last Update
December 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prolific
Remote/Online, United Kingdom